ClearPoint Neuro (CLPT) Current Deferred Revenue (2011 - 2026)

ClearPoint Neuro (CLPT) has 16 years of Current Deferred Revenue data on file, last reported at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 12.11% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 12.11% YoY), and the FY2025 full-year result was $1.7 million, down 21.31% from the prior year.
• Current Deferred Revenue rose to $1.8 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $3.2 million in Q4 2023 to a low of $541000.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.5 million in 2022 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue jumped 136.78% in 2023 and slumped 32.75% in 2024, its largest moves.
• Tracing CLPT's Current Deferred Revenue over 5 years: stood at $1.5 million in 2022, then jumped by 116.47% to $3.2 million in 2023, then tumbled by 32.75% to $2.1 million in 2024, then retreated by 21.31% to $1.7 million in 2025, then rose by 8.69% to $1.8 million in 2026.
• Business Quant data shows CLPT's Current Deferred Revenue at $1.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.